期刊
NEURON
卷 89, 期 5, 页码 940-947出版社
CELL PRESS
DOI: 10.1016/j.neuron.2016.02.024
关键词
-
资金
- National Institute of Mental Health (NIMH) [MH061399, MH097879, MH095797]
- National Alliance for Research in Schizophrenia and Depression (NARSAD) Young Investigator Award
- JSPS Postdoctoral Fellowship for Research Abroad
We analyze de novo synonymous mutations identified in autismspectrum disorders (ASDs) and schizophrenia (SCZ) with potential impact on regulatory elements using data from whole-exome sequencing (WESs) studies. Focusing on five types of genetic regulatory functions, we found that de novo near-splice site synonymous mutations changing exonic splicing regulators and those within frontal cortex-derived DNase I hypersensitivity sites are significantly enriched in ASD and SCZ, respectively. These results remained significant, albeit less so, after incorporating two additional ASD datasets. Among the genes identified, several are hit by multiple functional de novo mutations, with RAB2A and SETD1A showing the highest statistical significance in ASD and SCZ, respectively. The estimated contribution of these synonymous mutations to disease liability is comparable to de novo proteintruncating mutations. These findings expand the repertoire of functional de novo mutations to include functional'' synonymous ones and strengthen the role of rare variants in neuropsychiatric disease risk.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据